Policy and Power: Dismantling Middleman Dominance in Healthcare

Join hosts Michael Navin and Randy Vogenberg, PhD as they discuss more on the pivotal healthcare policy changes under the Trump administration. This episode delves into the fresh legislative adjustments affecting PBMs, the impacts of new Medicare reports, and advancements in gene therapy and R&D. It also discusses the broader implications of these policies on healthcare costs, accessibility, and the expansion of IVF coverage. Tune in for a critical analysis of what these changes mean for public and industry stakeholders and how they align with the "Make America Healthy Again" agenda.

Episode Highlights: 

• Introduction to Current Healthcare Policies: Explore the critical changes brought about by the new administration, including a focused look at the fresh legislative and administrative shifts in healthcare policy. 
  
  
• Detailed Look at Commercial Insurance and Government Programs: Delve into the specifics of recent legislative efforts around Pharmacy Benefit Managers (PBMs) and the implications of the latest reports from CMS and OIG on Medicare and healthcare costs. 
  
  
• The Role of R&D and New Therapies: Discuss the ongoing advancements in gene therapy and other R&D improvements, examining how they are poised to transform healthcare delivery. 
  
  
• Impacts of Policy on Healthcare Costs and Accessibility: Analyze how these policies are intended to shift costs between government and private programs, emphasizing out-of-pocket patient expenses. 
  
  
• IVF Coverage Expansion Discussion: Highlight the recent policy developments related to In Vitro Fertilization (IVF), including expanding coverage and its potential implications on healthcare insurance and patient access. 
  
  
• Future Directions and Continued Debates: Consider the expected developments in healthcare policy, including the potential impacts of the Make America Healthy Again agenda and the expanded use of novel therapies under the new FDA leadership. 

Michael's LinkedIn

Randy's LinkedIn

Sponsored by:
Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/.

Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.